AZTA
Price
$41.91
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
13 days until earnings call
RGEN
Price
$137.21
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Earnings call today
Ad is loading...

AZTA vs RGEN

Header iconAZTA vs RGEN Comparison
Open Charts AZTA vs RGENBanner chart's image
Azenta
Price$41.91
Change-$0.00 (-0.00%)
Volume$398.82K
CapitalizationN/A
Repligen
Price$137.21
Change-$0.00 (-0.00%)
Volume$389.63K
CapitalizationN/A
View a ticker or compare two or three
AZTA vs RGEN Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AZTA vs. RGEN commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and RGEN is a Hold.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AZTA: $41.91 vs. RGEN: $137.21)
Brand notoriety: AZTA and RGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 61% vs. RGEN: 56%
Market capitalization -- AZTA: $3.36B vs. RGEN: $10.26B
AZTA [@Medical Specialties] is valued at $3.36B. RGEN’s [@Medical Specialties] market capitalization is $10.26B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 2 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 4 bearish.
  • RGEN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than RGEN.

Price Growth

AZTA (@Medical Specialties) experienced а -4.18% price change this week, while RGEN (@Medical Specialties) price change was -8.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 11, 2025.

RGEN is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($10.3B) has a higher market cap than AZTA($3.36B). RGEN YTD gains are higher at: -23.687 vs. AZTA (-35.662). RGEN has higher annual earnings (EBITDA): 134M vs. AZTA (57.5M). AZTA has more cash in the bank: 984M vs. RGEN (751M). AZTA has less debt than RGEN: AZTA (66.5M) vs RGEN (712M). AZTA (641M) and RGEN (639M) have equivalent revenues.
AZTARGENAZTA / RGEN
Capitalization3.36B10.3B33%
EBITDA57.5M134M43%
Gain YTD-35.662-23.687151%
P/E RatioN/A247.52-
Revenue641M639M100%
Total Cash984M751M131%
Total Debt66.5M712M9%
FUNDAMENTALS RATINGS
AZTA vs RGEN: Fundamental Ratings
AZTA
RGEN
OUTLOOK RATING
1..100
525
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
9270
SMR RATING
1..100
9389
PRICE GROWTH RATING
1..100
8560
P/E GROWTH RATING
1..100
721
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (66) in the Electronic Production Equipment industry is in the same range as RGEN (93) in the Biotechnology industry. This means that AZTA’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as AZTA (92) in the Electronic Production Equipment industry. This means that RGEN’s stock grew similarly to AZTA’s over the last 12 months.

RGEN's SMR Rating (89) in the Biotechnology industry is in the same range as AZTA (93) in the Electronic Production Equipment industry. This means that RGEN’s stock grew similarly to AZTA’s over the last 12 months.

RGEN's Price Growth Rating (60) in the Biotechnology industry is in the same range as AZTA (85) in the Electronic Production Equipment industry. This means that RGEN’s stock grew similarly to AZTA’s over the last 12 months.

RGEN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for AZTA (72) in the Electronic Production Equipment industry. This means that RGEN’s stock grew significantly faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTARGEN
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.54%
CRL - AZTA
65%
Loosely correlated
+2.42%
IQV - AZTA
56%
Loosely correlated
+1.36%
TMO - AZTA
54%
Loosely correlated
-0.33%
TWST - AZTA
54%
Loosely correlated
+4.73%
RVTY - AZTA
53%
Loosely correlated
+1.00%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+1.30%
DHR - RGEN
66%
Closely correlated
-0.52%
TMO - RGEN
57%
Loosely correlated
-0.33%
WAT - RGEN
55%
Loosely correlated
+0.30%
A - RGEN
54%
Loosely correlated
+1.04%
AZTA - RGEN
53%
Loosely correlated
+2.54%
More